Cosmo Bio Co (TSE:3386) Accounts Payable & Accrued Expense : 円933 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Cosmo Bio Co Accounts Payable & Accrued Expense?

Cosmo Bio Co's quarterly accounts payable & accrued expense declined from Jun. 2023 (円723 Mil) to Sep. 2023 (円634 Mil) but then increased from Sep. 2023 (円634 Mil) to Dec. 2023 (円933 Mil).

Cosmo Bio Co's annual accounts payable & accrued expense declined from Dec. 2021 (円911 Mil) to Dec. 2022 (円815 Mil) but then increased from Dec. 2022 (円815 Mil) to Dec. 2023 (円933 Mil).

Cosmo Bio Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cosmo Bio Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Bio Co Accounts Payable & Accrued Expense Chart

Cosmo Bio Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

795.00

999.00

911.00

815.00

933.00

Cosmo Bio Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															815.00	813.00	723.00	634.00	933.00

Cosmo Bio Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cosmo Bio Co (TSE:3386) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cosmo Bio Co Ltd (TSE:3386) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016

Website

http://www.cosmobio.co.jp

Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes purchase of reagents, instruments, clinical test drugs for research on life science and domestic sales.

Cosmo Bio Co (TSE:3386) Headlines

No Headlines